Wolfe Josh 4
4 · Eikon Therapeutics, Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Eikon (EIKN) 10% Owner Josh Wolfe Sells Shares After Conversions
What Happened
Josh Wolfe (reported as a 10% owner) made two open‑market purchases on Feb 4, 2026 — 138,888 shares each at $18.00 per share (total 277,776 shares; $4,999,968). On Feb 6, 2026 the Form 4 shows multiple "conversion of derivative security" transactions: those conversions recorded acquisitions totaling 5,972,786 shares and dispositions totaling 42,472,241 shares (net decrease of 36,499,455 shares). The conversion entries have no per‑share price reported (N/A) and are labeled as derivative conversions.
Key Details
- Purchase(s): 2026-02-04 — two open‑market buys of 138,888 shares @ $18.00 each; total cash ~$5.0M.
- Derivative conversions: 2026-02-06 — multiple conversion entries (some show acquired shares, many show disposed shares); values reported as N/A.
- Net change on record: acquired 5,972,786 shares vs. disposed 42,472,241 shares → net decrease ≈ 36,499,455 shares.
- Shares owned after transactions: not stated in the provided excerpt of the filing.
- Footnotes: many shares are held by Lux-affiliated entities (see F1–F9) and certain preferred series previously converted to common on an IPO 1-for-7.4578 basis (F2–F10). Lux entities’ general partners and individual Lux managers (including Wolfe) are noted; they disclaim beneficial ownership except to extent of pecuniary interest.
- Timeliness: Report filed Feb 6, 2026 for transactions through Feb 4/6, 2026 — appears timely (not marked late).
Context
- "Conversion of derivative security" typically means non‑cash conversions (e.g., preferred shares, warrants, or other convertible instruments converted into common stock); the filing shows many such conversions with no cash price reported.
- Dispositions labeled as derivative conversions do not necessarily indicate open‑market sell orders — they often reflect structural changes in holdings (conversions, transfers between affiliated entities, or similar).
- As a 10% owner and manager of Lux-related funds, Wolfe’s reported activity largely involves institutional/affiliated positions; such filings can reflect fund-level restructurings rather than personal trading decisions.
If you want, I can check the full Form 4 PDF (accession 0001193125-26-041549) to extract the post‑transaction ownership totals and any additional footnote text.
Insider Transaction Report
Form 4
Wolfe Josh
Director10% Owner
Transactions
- Purchase
Common Stock
[F1]2026-02-04$18.00/sh+138,888$2,499,984→ 138,888 total(indirect: See footnote) - Purchase
Common Stock
[F2]2026-02-04$18.00/sh+138,888$2,499,984→ 138,888 total(indirect: See footnote) - Conversion
Common Stock
[F3][F4][F5]2026-02-06+2,387,705→ 2,387,705 total(indirect: See footnote) - Conversion
Common Stock
[F4][F6][F7][F1]2026-02-06+1,151,540→ 1,290,428 total(indirect: See footnote) - Conversion
Common Stock
[F6][F7][F8][F9][F10][F2]2026-02-06+2,155,765→ 2,294,653 total(indirect: See footnote) - Conversion
Series A Preferred Stock
[F3][F5]2026-02-06−10,000,000→ 0 total(indirect: See footnote)→ Common Stock (1,340,878 underlying) - Conversion
Series A-1 Preferred Stock
[F4][F5]2026-02-06−7,807,026→ 0 total(indirect: See footnote)→ Common Stock (1,046,827 underlying) - Conversion
Series A-1 Preferred Stock
[F4][F1]2026-02-06−2,502,252→ 0 total(indirect: See footnote)→ Common Stock (335,521 underlying) - Conversion
Series B Preferred Stock
[F6][F1]2026-02-06−796,380→ 0 total(indirect: See footnote)→ Common Stock (106,785 underlying) - Conversion
Series B Preferred Stock
[F6][F2]2026-02-06−530,920→ 0 total(indirect: See footnote)→ Common Stock (71,190 underlying) - Conversion
Series B-1 Preferred Stock
[F7][F1]2026-02-06−5,289,322→ 0 total(indirect: See footnote)→ Common Stock (709,234 underlying) - Conversion
Series B-1 Preferred Stock
[F7][F2]2026-02-06−3,526,215→ 0 total(indirect: See footnote)→ Common Stock (472,822 underlying) - Conversion
Series C Preferred Stock
[F8][F2]2026-02-06−303,360→ 0 total(indirect: See footnote)→ Common Stock (40,677 underlying) - Conversion
Series C-1 Preferred Stock
[F9][F2]2026-02-06−1,450,614→ 0 total(indirect: See footnote)→ Common Stock (194,510 underlying) - Conversion
Series D Preferred Stock
[F10][F2]2026-02-06−10,266,152→ 0 total(indirect: See footnote)→ Common Stock (1,376,566 underlying)
Footnotes (10)
- [F1]These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
- [F10]The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
- [F2]These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
- [F3]The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date.
- [F4]The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
- [F5]These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
- [F6]The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
- [F7]The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
- [F8]The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
- [F9]The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.
Signature
/s/ Benjamin Thorner, Attorney in Fact|2026-02-06